Skip to main content
. 2023 Jul 21;63(5):1251–1258. doi: 10.1093/rheumatology/kead368

Figure 5.

Figure 5.

Cumulative incidence function curves of PH-specific and non-PH mortality for SSc-PH patients enrolled in the PHAROS registry with different pericardial effusion status. P-values were calculated by Gray’s test. PH: pulmonary hypertension